XML 33 R20.htm IDEA: XBRL DOCUMENT v3.21.2
Inventory (Tables)
9 Months Ended
Sep. 30, 2021
Inventory Disclosure [Abstract]  
Schedule of Inventory

The Company capitalizes its purchases of saleable inventory of VASCEPA from suppliers that have been qualified by the U.S. FDA. Inventories as of September 30, 2021 and December 31, 2020 consist of the following:

 

In thousands

 

September 30, 2021

 

 

December 31, 2020

 

Raw materials

 

$

71,838

 

 

$

50,657

 

Work in process

 

 

39,521

 

 

 

30,388

 

Finished goods

 

 

197,909

 

 

 

107,819

 

Total inventory

 

$

309,268

 

 

$

188,864